CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015

Share Article

Annual list showcases the 20 Most Promising Pharma and Life Sciences Technology Solution Providers.

SIGNiX’s digital signature products are trusted by global clinical research organizations, reaching thousands of physicians and hundreds of thousands of patients.

SIGNiX’s digital signature products are trusted by global clinical research organizations, reaching thousands of physicians and hundreds of thousands of patients.

SIGNiX has been on our radar for some time for stirring a revolution in the Pharma and Life Sciences Technology space, and we are happy to showcase them this year due to their continuing excellence in delivering a top-notch, technology-driven solution.

CIO Review has chosen SIGNiX for its list of the 20 Most Promising Pharma and Life Sciences Technology Solution Providers. The positioning is based on an evaluation of SIGNiX’s 21 CFR Pat 11 compliant solution which is applicable across the entire security spectrum of transactions within life sciences, while retaining the ease-of-use necessary for broad adoption.

“SIGNiX has been on our radar for some time for stirring a revolution in the Pharma and Life Sciences Technology space, and we are happy to showcase them this year due to their continuing excellence in delivering a top-notch technology-driven solution,” said Harvi Sachar, Publisher and Founder, CIO Review. “SIGNiX continued to break new ground within the past year, benefiting its customers around the globe, and we’re excited to have them featured on our top companies list.”

SIGNiX’s digital signature products are trusted by global clinical research organizations, reaching thousands of physicians and hundreds of thousands of patients. Market leaders choose SIGNiX because it is the only digital signature vendor to provide:

  • Compliance: SIGNiX’s technology is based on international standards by default and at no extra charge. They comply with stringent industry requirements, including the FDA’s 21 CFR Part 11, HIPAA, the ESIGN Act, UETA, NIST, ETSI and SSAE16, among others. Clinical research organizations (CROs) choose SIGNiX because documents signed with SIGNiX are secure, portable, self-contained and compliant with international regulations.
  • Scalability: SIGNiX’s digital signatures can be used for every signature a company needs—from internal HR documents to clinical trial submissions. They can customize each transaction based on its level of risk and compliance.
  • Integration: SIGNiX is a flexible digital signature service that easily integrates into existing systems with their web services API. Every aspect of a transaction can be customized to reflect any brand. SIGNiX can speed up site and study initiation while also lowering site onboarding costs.

A panel of experts and members of CIO Review’s Editorial Board select the annual list of companies to recognize and promote technology entrepreneurship.

“SIGNiX offers an ideal digital signature solution for this highly regulated and security conscious market, and we are honored to be recognized by CIO Review’s panel of experts and thought leaders,” said Jay Jumper, CEO.

About SIGNiX
SIGNiX, the most trusted name in independent e-signatures, makes signing documents online safe and secure with comprehensive legal evidence permanently embedded in each document to eliminate any dependence upon. SIGNiX’s cloud-based service uses patented technology to give businesses and organizations the most secure and legally defensible e-signatures available at a fraction of the cost of ink signatures. SIGNiX’s products help the world’s leading companies become more efficient, decrease risk and boost profits. For more information, visit http://www.signix.com.

About CIO Review
CIO Review constantly endeavors to identify "The Best" in a variety of areas important to tech business. Through nominations and consultations with industry leaders, our editors choose the best in different domains. Pharma and Life Sciences Technology Special edition is an annual listing of the 20 Most Promising Pharma and Life Sciences Technology Solution Providers in the U.S.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Emily Maxie
SIGNiX
+1 423-305-7047
Email >
Visit website